Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Syndax Pharmaceuticals Inc’s stock clocked out at $10.54, down -0.75% from its previous closing price of $10.62. In other words, the price has decreased by -$0.75 from its previous closing price. On the day, 1.81 million shares were traded.
Ratios:
To gain a deeper understanding of SNDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.75 and its Current Ratio is at 5.80. In the meantime, Its Debt-to-Equity ratio is 1.61 whereas as Long-Term Debt/Eq ratio is at 1.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On June 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $37.
Scotiabank Downgraded its Sector Outperform to Sector Perform on January 31, 2024, whereas the target price for the stock was revised from $36 to $23.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Botwood Nicholas A.J. bought 11,765 shares for $8.99 per share. The transaction valued at 105,826 led to the insider holds 35,165 shares of the business.
Huber Martin H. Jr. bought 5,000 shares of SNDX for $44,950 on May 19 ’25. The Director now owns 79,000 shares after completing the transaction at $8.99 per share. On May 19 ’25, another insider, Katkin Keith, who serves as the Director of the company, bought 10,000 shares for $9.11 each. As a result, the insider paid 91,120 and bolstered with 100,000 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 20.74 while its Price-to-Book (P/B) ratio in mrq is 4.22.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.07, while it has fallen to a 52-week low of $8.58. The 50-Day Moving Average of the stock is -10.04%, while the 200-Day Moving Average is calculated to be -31.53%.
Shares Statistics:
A total of 86.05M shares are outstanding, with a floating share count of 82.47M. Insiders hold about 4.16% of the company’s shares, while institutions hold 115.48% stake in the company.
